Inozyme Pharma Inc (OQ:INZY)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for INZY within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET August 6th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jul 29/20 Jul 28/20 Novo Holdings A/S Direct Ownership SERIES A-2 CONVERTIBLE PREFERRED STOCK C - Conversion -1,398,600  
Jul 29/20 Jul 28/20 Novo Holdings A/S Direct Ownership SERIES A CONVERTIBLE PREFERRED STOCK C - Conversion -15,000,000  
Jul 29/20 Jul 28/20 Novo Holdings A/S Direct Ownership COMMON STOCK P - Open market or private purchase 375,000 $16.00
Jul 29/20 Jul 28/20 Novo Holdings A/S Direct Ownership COMMON STOCK C - Conversion 2,194,379  
Jul 28/20 Jul 28/20 Sonsini Peter W. Indirect Ownership Common Stock P - Open market or private purchase 250,000 $16.00
Jul 28/20 Jul 28/20 Sonsini Peter W. Indirect Ownership Common Stock C - Conversion 187,156  
Jul 28/20 Jul 28/20 Sonsini Peter W. Indirect Ownership Common Stock C - Conversion 2,000,533  
Jul 28/20 Jul 28/20 Sandell Scott D Indirect Ownership Common Stock P - Open market or private purchase 250,000 $16.00
Jul 28/20 Jul 28/20 Sandell Scott D Indirect Ownership Common Stock C - Conversion 187,156  
Jul 28/20 Jul 28/20 Sandell Scott D Indirect Ownership Common Stock C - Conversion 2,000,533  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for INZY within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET August 6th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jul 29/20 Jul 28/20 Novo Holdings A/S Direct Ownership SERIES A-2 CONVERTIBLE PREFERRED STOCK C - Conversion -1,398,600  
Jul 29/20 Jul 28/20 Novo Holdings A/S Direct Ownership SERIES A CONVERTIBLE PREFERRED STOCK C - Conversion -15,000,000  
Jul 29/20 Jul 28/20 Novo Holdings A/S Direct Ownership COMMON STOCK P - Open market or private purchase 375,000 $16.00
Jul 29/20 Jul 28/20 Novo Holdings A/S Direct Ownership COMMON STOCK C - Conversion 2,194,379  
Jul 29/20 Jul 28/20 Sanofi Indirect Ownership Series A Convertible Preferred Stock (par value, $0.0001) C - Conversion -3,279,720  
Jul 29/20 Jul 28/20 Sanofi Indirect Ownership Common Stock (par value $0.0001) P - Open market or private purchase 81,250 $16.00
Jul 29/20 Jul 28/20 Sanofi Indirect Ownership Common Stock (par value $0.0001) C - Conversion 438,875  
Jul 28/20 Jul 25/20 Sonsini Peter W. Indirect Ownership Series A-2 Preferred Stock C - Conversion -187,156  
Jul 28/20 Jul 25/20 Sonsini Peter W. Indirect Ownership Series A Preferred Stock C - Conversion -2,000,533  
Jul 28/20 Jul 28/20 Sonsini Peter W. Indirect Ownership Common Stock P - Open market or private purchase 250,000 $16.00
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $INZY

  • No tweets found

Competitors

Competitors with Recent Insider Filings
Iqvia Holdings (N:IQV)
Moderna (OQ:MRNA)
Biohaven Pharmaceutical H (N:BHVN)

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.